Cargando…
A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
Treatment of non-small cell lung cancer (NSCLC) is challenging in many ways. One of the problems is disappointing local control rates in larger volume disease. Moreover, the likelihood of both nodal and distant spread increases with primary tumour (T-) stage. Many patients are elderly and have consi...
Autores principales: | Nieder, Carsten, Pawinski, Adam, Dalhaug, Astrid, Andratschke, Nicolaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269364/ https://www.ncbi.nlm.nih.gov/pubmed/22236606 http://dx.doi.org/10.1186/1748-717X-7-3 |
Ejemplares similares
-
Combined Radio- and Chemotherapy for Non-Small Cell Lung Cancer: Systematic Review of Landmark Studies Based on Acquired Citations
por: Nieder, Carsten, et al.
Publicado: (2013) -
Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers?
por: Nieder, Carsten, et al.
Publicado: (2014) -
Continuous controversy about radiation oncologists’ choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?
por: Nieder, Carsten, et al.
Publicado: (2013) -
The Glasgow prognostic score: Useful information when prescribing palliative radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2017) -
Survival Prediction Score: A Simple but Age-Dependent Method Predicting Prognosis in Patients Undergoing Palliative Radiotherapy
por: Angelo, Kent, et al.
Publicado: (2014)